期刊文献+

串联质谱技术在惠州市新生儿遗传代谢病筛查中的应用价值分析 被引量:2

Application Value Analysis of Tandem Mass Spectrometry in Screening of Neonatal Genetic Metabolic Diseases
下载PDF
导出
摘要 目的分析串联质谱技术在惠州市新生儿遗传代谢病筛查中的应用价值。方法选择惠州市第二妇幼保健院2017年1月—2017年6月筛查病例5000例新生儿作为观察对象,均开展串联质谱技术的新生儿遗传代谢病筛查,观察串联质谱技术在新生儿遗传代谢性病筛查中的价值。结果5000例新生儿中确诊为遗传代谢病的患儿16例,其中脂肪酸代谢异常患儿3例,有机酸代谢异常患儿4例,氨基酸代谢异常患儿9例,筛查的敏感性高达100.00%,确诊后针对患儿展开针对性干预及治疗后随访发现存在3例智力发育障碍、代谢紊乱及运动发育迟缓患儿。结论在新生儿遗传代谢病筛查过程中实施串联质谱技术的效果十分显著,具有较高的敏感性及特异性,为患儿预后及治疗奠定基础。 Objective To analyze the application value of tandem mass spectrometry in screening of neonatal genetic metabolic diseases. Methods 5 000 cases of neonates screened in the hospital from January,2017 to June,2017 were selected as observation objects. Screening of neonatal genetic metabolic diseases by tandem mass spectrometry was carried out,and the value of tandem mass spectrometry in screening of neonatal genetic metabolic diseases was observed. Results 16 in 5 000 neonatal cases were diagnosed as inherited metabolic disease,in which children with fatty acid metabolism in 3 patients,organic acid metabolism in 4 patients,and amino acid metabolic abnormalities in 9 patients. The sensitivity of the screening was as high as 100. 00%. After diagnosis for children with a targeted intervention and follow-up after treatment,3 cases of developmental disorders,metabolic disorders and developmental delay were found. Conclusion The application of tandem mass spectrometry in screening of neonatal genetic and metabolic diseases is very effective,and has high sensitivity and specificity,laying a foundation for the prognosis and treatment of the children.
作者 吴浪波 陈翔 WU Lang-bo;CHEN Xiang(Clinical laboratory, Huizhou Second Maternal and Child Health Hospital, Huizhou, Guangdong, 516000,China)
出处 《黑龙江医学》 2019年第5期519-520,共2页 Heilongjiang Medical Journal
关键词 串联质谱技术 惠州 新生儿遗传代谢病 筛查 Tandem mass spectrometry Huizhou Genetic metabolic disease of newborn Screening
  • 相关文献

参考文献4

二级参考文献37

  • 1胡晓舟,张捷.医学检验中液相色谱-串联质谱的应用[J].临床检验杂志,2005,23(4):314-316. 被引量:7
  • 2谷俊朝,马涛,王宇.甘氨酸保护作用机制与相关疾病探讨[J].北京医学,2005,27(9):560-563. 被引量:30
  • 3Gulack BC,Schweitzer M,Englum BR,et al.Predictors of gastrostomy placement in children with inherited metabolic diseases treated by umbilical cord blood transplantation[J].J Pediatr Surg,2015,50(7):1109-1111.
  • 4Millington DS,Kodo N,Norwood DL,et al.Tandem mass spectrometry:a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism[J].J Inherit Metab Dis,1990,13(3):321-324.
  • 5Vogiatzis CG,Zachariadis GA.Tandem mass spectrometry in metallomics and the involving role of ICP-MS detection:a review[J].Anal Chim Acta,2014,819:114.
  • 6Hui J,Tang NL,Li CK,et al.Inherited metabolic diseases in the southern Chinese population:spectrum of diseases and estimated incidence from recurrent mutations[J].Pathology,2014,46(5):375-382.
  • 7Kuehn BM. After 50 years, newborn screening continues to yield public health gains [J]. JAMA, 2013, 309 (12) : 1215-1217. DOI : 10. 1001/jama. 2013. 2087.
  • 8Mechder TP, Stary S, Metz TF, et al. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria [ J ]. Lancet, 2012,379 ( 9813 ) : 335- 341. DOI : 10. 1016/S0140-6736 ( 11 ) 61266-X.
  • 9Demirev PA. Dried blood spots:analysis and applications[ J]. Anal Chem,2013,85 ( 2 ) :779-789. DOI: 10. 1021/ac303205m.
  • 10De Jestls VR, Mei JV, Cordovado SK, et al. The newborn screening quality assurance program at the centers for disease control and prevention:thirty-five year experience assuring newborn screening laboratory quality[ J]. Int J Neonatal Screen,2015,1 ( 1 ) : 13-26. DOI : 10. 3390/ijns1010013.

共引文献78

同被引文献18

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部